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A Case of Pulmonary Alveolar Microlithiasis
Pulmonary alveolar microlithiasis (PAM) is a rare disease with unknown etiology and 
pathogenesis. It is characterized by diffuse, innumerable, and minute calculi, called 
microlithiasis in the alveoli. More than half of reported cases are asymptomatic at the time 
of diagnosis. We describe the first case of PAM in Korea. A 19-yr-old man without 
respiratory symptoms presented with interstitial thickening on the chest radiograph. His 
chest high resolution CT scan showed diffusely scattered, ill defined tiny micronodules and 
interstitial thickening. Open lung biopsy confirmed the diagnosis of PAM. He was followed 
up for 6 months without treatment, and no progression was noticed.
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CASE REPORT
Respiratory Diseases
INTRODUCTION 
Pulmonary alveolar microlithiasis (PAM) is a rare and chronic 
lung disease, characterized by the presence of small round bod-
ies containing concentric calcareous lamellas in pulmonary al-
veoli (1-3). The disease could remain asymptomatic for decades, 
with subsequent occurrence of dyspnea, chest pain, and dry 
cough, and could result in respiratory failure (3). Half of the pa-
tients were asymptomatic at the time of diagnosis; therefore, 
most reported cases were diagnosed during a routine examina-
tion (1-3). Characteristic radiologic findings consist of bilateral 
innumerous calcified nodules, which might suggest the disease, 
and it is subsequently confirmed with a less invasive procedure, 
such as bronchoscopy (4). Most cases of PAM in Asia have been 
reported in Turkey, India, and Japan (1-3). However, no case has 
been reported in Korea. Here we reported on the first case of 
PAM in Korea, confirmed by open lung biopsy. 
CASE DESCRIPTION
A 19-yr-old male exhibiting no respiratory symptoms visited our 
hospital on November 9, 2010 for evaluation of abnormalities 
noted on a chest radiogram of a routine health check for military 
service. He was a current smoker with a smoking history of 1.5 
pack years. He had eight elder sisters, but no family history dis-
closing pulmonary disease. On admission, the patient had evi-
denced no abnormal physical findings, and laboratory data were 
also normal. Results of the pulmonary function test were also 
normal; an FVC of 4.48 liters (115% predicted), a normal FEV1 
of 3.83 liters (107% predicted), and a FEV1/FVC ratio of 85%. Dif-
fusion capacity study showed a DLCO of 33.4 mL/mmHg/min 
(126% predicted).
  A chest radiogram taken on the day of his visit showed bilat-
eral, diffuse, fine reticulonodular opacities in both lungs (Fig. 1). 
High resolution CT (HRCT) scan revealed scattered micronod-
ules, interlobular septal thickening, subpleural interstitial thick-
ening, and some areas of ground-glass opacity. Subpleural cys-
tic changes and microcalcifications along the subpleural regions 
and some interlobar septa were also observed (Fig. 2). 
  Bronchoscopy was performed. Cell analysis of bronchoalve-
oloar lavage (BAL) fluid showed 80% in lymphocytes and 15% 
in monocytes. BAL fluid was negative for tuberculosis, malig-
nancy, or microliths. Transbronchial lung biopsy showed a few 
alveolar tissues with multiple calcified nodules. Video-assisted 
thoracoscopic surgery (VATS) was performed for pathologic con-
firmation. Histological findings of VATS biopsy showed multi-
ple round small calcified nodules in the visceral pleura and the 
alveolar wall, consistent with the diagnosis of PAM (Fig. 3). 
  The patient was followed up in out-patient clinic for 6 months 
without progression of the disease and had no treatment for PAM.
DISCUSSION
This is the first report on a case of PAM in Korea. PAM is a rare 
disease and has been reported with no particular geographic or 
racial distribution; however, Europe is the most prevalent area, Kang HW, et al.  •  Pulmonary Alveolar Microlithiasis
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followed by Asia, particularly Turkey, India, and Japan (1, 2). How-
ever, no case of PAM has been reported in Korea. 
  The etiology of the disease is still unknown. A genetic factor 
has been supposed because of familial occurrence (1, 2). Recent-
ly, a mutation in the SCL34A2 gene, which encodes a type IIb 
sodium dependent phosphate transporter, was suggested as a 
pathogenesis of this disease (5). CL34A2 is primarily expressed 
in alveolar type II cells responsible for surfactant production us-
ing phospholipids and plays a major role in homeostasis of inor-
ganic phosphate (5). Therefore, dysfunction in CL34A2 can result 
in accumulation of phosphorus ion in alveolar space and is like-
ly the cause of PAM. In this case, none of the family members of 
the patient had experienced any type of respiratory illness.
  There was no sex difference in the rate of occurrence in re-
ported cases and it was most frequently discovered from birth 
up to 40 yr of age (1-3). Due to the inability to certify clear etio-
logical and pathogenic factors, a therapeutic approach is diffi-
cult, and there is currently no effective medical treatment for this 
disease and affected individuals may progress to respiratory fail-
ure. Therefore, lung transplantation should be considered in end 
Fig. 1. Chest radiogram (posteroanterior view) shows bilateral diffuse fine reticulo-
nodular opacities in both lungs. 
Fig. 2. Chest CT images of a patient with pulmonary alveolar microlithiasis. (A) HRCT image at the level of basal lung zone shows micronodules (white arrows), inter lobular septal 
thickening (black arrows), subpleural interstitial thickening (arrow heads), and some areas of ground- glass opacity (asterisk). (B) HRCT image at the level of apical lung zone shows 
micronodules (white arrows) and subpleural cystic changes (black arrows). (C, D) Mediastinal window scans show microcalcifications along the subpleural regions and some in-
terlobar septa.
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Fig. 3. Histological findings of video-assisted thoracoscopic surgery biopsy. (A) Small calcified nodules were scattered along the alveolar walls (H&E stained, × 20). (B) The small 
nodule was proved to be a lamellar microlith (H&E, × 200).
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stage PAM, where either severe respiratory failure or right heart 
failure is present (6-8). 
  Precise assessment of the history of alveolar microlithiasis is 
difficult. Therefore, in many cases, the diagnosis is made as an 
incidental radiographic film in symptomless patients (3). The 
chest radiograph usually revealed small innumerable, wide-
spread, and calcified nodules, which tend to be greatest at the 
base (4, 9, 10). HRCT scan has aided in characterization of the 
imaging of the disease and can be useful in diagnosis (4, 9, 10). 
Ground-glass opacities due to volume averaging of tiny micro-
liths are a common and major finding in the literature (4, 9, 10). 
Subpleural linear calcification and nodular fissural thickening 
are also a common finding (4, 9, 10). In this case, these findings 
were also observed on his chest CT. Although specific findings 
in HRCT scan could lead to diagnosis of PAM, other cases of 
diffuse pulmonary calcification should be considered for dif-
ferential diagnosis, including metastatic pulmonary calcifica-
tion, amyloidosis, and dendriform pulmonary ossification (11). 
However, clinician’s awareness of typical HRCT findings of this 
disease could lead to diagnosis using less invasive procedures. 
Therefore, most recently reported cases of PAM were diagnosed 
by transbronchial biopsy and BAL (1). In this case, due to lack 
of experience with this disease, we performed open lung biopsy 
for diagnosis. 
  In conclusion, PAM is a rare disease that can present with no 
symptoms. Characteristic HRCT findings can aid in diagnosis 
of this disease using less invasive procedures. 
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